国际皮肤性病学杂志    2004 30 (3): 140-142   ISSN: 2096-5540  CN: 32-1880/R   白癜风局部治疗的新进展 蔡永伟, 许爱娥 杭州市第三人民医院皮肤科 310009 收稿日期 2003-08-14  修回日期 null  网络版发布日期 null 参考文献  [1] Tanghetti EA. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series. Cuffs,2003, 71:158-162. [2] Castanedo-Cazares JP, Lepe V, Moncada B. Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrowband. Photodermatol Photoimmunol Photomed, 2003, 19:35-36. [3] Lepe V, Moncada B, Castanedo-Cazares JP, et al. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol, 2003, 139:581-585. [4] Parsad D, Pandhi R, Dogra S, et al. Topical prostaglandin analog (PGE2) in vitiligo-a preliminary study. Int J Dermatol, 2002, 41:942-945. [5] Prota G, Vincensi MR, Napolitano A, et al. Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys. Pigment Cell Res, 2000, 13:147-150. [6] Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol, 1999, 16:317-320. [7] Amenn M,Chu C. Treatment vitiligo with topical calcipotriol. Br J Dermatol, 1999, 141:43-48. [8] Kose O, Riza Gur A, Kurumlu Z, et al. Calcipotriol ointment versus clobetasol ointment in localized vitiligo: an open, comparative clinical trial. Int J Dermatol, 2002, 41:616-618. [9] Ermis O, Alpsoy E, Cetin L, et al. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol, 2001,145:472-475. [10] Yu HS, Wu CS, Yu CL,et al. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo. J Invest Dermatol, 2003, 120:56-64. [11] Toyoda M, Luo Y, Makino T, et al. Calcitonin gene-related peptide upregulates melanogenesis and enhances melanocyte dendricity via induction of keratinocyte-derived melanotrophic factors. J Investig Dermatol Symp Proc, 1999, 4:116-125. [12] Baltas E, Csoma Z, lgnacz F, et al. Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol, 2002, 138:1619-1620. [13] Baltas E, Nagy P, Bonis B, et al. Repigmentation of localized vitiligo with the xenon chloride laser. Br J Dermatol, 2001, 144:1266-1267. [14] Friedman PM, Geronemus RG. Use of the 308-nm excimer laser for postresurfacing leukoderma. Arch Dermatol, 2001, 137:824-825. [15] Novak Z, Bonis B, Baltas E,et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J Photochem Photobiol B, 2002, 67:32-38. [16] Glaser R, Rowert J, Mrowietz U. Hyperpigmentation due to topical calcipotriol and photochemotherapy in two psoriatic patients. Br J Dermatol, 1998, 139:148-151. [17] Rutter A, Schwarz T. Market hyperpigmentation in psoriatic plaque as a sequelae of combination therapy with UVB-311 and calcipotriol.Hautarzt, 2000, 51:431-433. [18] Tjioe M, Gerritsen MJ, Juhlin L,et al. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol, 2002, 82:369-372. [19] Dogra S, Parsad D. Combination of narrowband UV-B and topical caleipotriene in vitiligo. Arc h Dermatol, 2003,139:393. 通讯作者: